Subscribe to RSS
DOI: 10.1055/s-2006-951828
Die Erfassung psychosozialer Belastungen und Ressourcen in der Onkologie - Ein Literaturüberblick zu Screeningmethoden und Entwicklungstrends
Assessment of Psychosocial Distress and Resources in Oncology - A Literature Review About Screening Measures and Current DevelopmentsPublication History
eingereicht 18. August 2005
akzeptiert 7. Oktober 2006
Publication Date:
06 December 2006 (online)
![](https://www.thieme-connect.de/media/ppmp/200612/lookinside/thumbnails/10.1055-s-2006-951828-1.jpg)
Zusammenfassung
Ein substanzieller Anteil von Krebspatienten weist im Verlauf der Erkrankung und deren Behandlung psychische Belastungsreaktionen auf, die sich bis hin zu schweren psychischen Störungen und psychosozialen Krisen entwickeln können. In der onkologischen Versorgung wird gegenwärtig jedoch nur ein Teil dieser behandlungsbedürftigen Störungen erkannt und angemessen behandelt. Das Wissen über und das Screening von psychosozialen Belastungen und psychischen Störungen bei Krebspatienten ist deshalb für die Verbesserung der psychosozialen Versorgung ein dringendes Anliegen. Der Beitrag gibt zunächst einen Überblick über psychosoziale Belastungen und die Epidemiologie psychischer Störungen bei Krebspatienten. Anschließend werden wichtige Zielsetzungen und Probleme der psychosozialen Diagnostik bei Krebspatienten erläutert und im onkologischen Setting häufig eingesetzte Fragebogen und Screeningverfahren zur Erfassung von psychosozialen Belastungen, von psychischen Störungen, von personellen und sozialen Ressourcen und der gesundheitsbezogenen Lebensqualität dargestellt.
Abstract
A substantial percentage of cancer patients suffers from psychosocial distress to severe mental disorders and psychosocial crisis during the course of the illness and cancer treatment. However, only a small percentage of patients with severe psychosocial distress and mental disorders in the present oncological practice is accurately identified, diagnosed, and appropriately treated. Therefore, sufficiant knowledge about psychosocial distress and mental disorders as well as screening procedures are urgent concerns to improve psychosocial care for cancer patients. First, the article provides an overview of psychosocial distress and the epidemiology of mental disorders in cancer patients. Then a few of the most important objectives and problems of psychosocial assessment in cancer patients will be explained. The following part will offer an overview of questionnaires and screening procedures that are frequently used to assess psychosocial distress, mental disorders, personal and social resources, and health related quality of life in cancer patients.
Schlüsselwörter
Psychosoziale Belastungen - Ressourcen - Krebs - Screening
Key words
psychosocial distress - resources - cancer - screening
Literatur
- 1 Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. und das Robert Koch-Institut .Krebs in Deutschland. 5. überarbeitete, aktualisierte Ausgabe. Saarbrücken; 2006
- 2 Haberland J, Bertz J, Gorsch B. et al . Die zukünftige Entwicklung des Krebsgeschehens in Deutschland. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2006; 49 459-467
- 3 Holland J C, Breitbart W, Jacobsen P B, Lederberg M S. Psycho-Oncology. New York; Oxford University Press 1998
- 4 Koch U, Weis J (Hrsg). Krankheitsbewältigung bei Krebs und Möglichkeiten der Unterstützung. Stuttgart; Schattauer 1998
- 5 Holland J C, Reznik I. Pathways for psychosocial care of cancer survivors. Cancer. 2004; 104 2624-2637
- 6 Sellick S M, Crooks D L. Depression and cancer: An appraisal of the literature for prevalence, detection, and practice guideline development for psychological interventions. Psychooncology. 1999; 8 315-333
- 7 Stark D P, House A. Anxiety in cancer patients. Br J Cancer. 2000; 83 1261-1267
- 8 Härter M, Reuter K, Aschenbrenner A. et al . Psychiatric disorders and associated factors in cancer: results of an interview study with patients in inpatient, rehabilitation and outpatient treatment. Eur J Cancer. 2001; 37 (11) 1385-1393
- 9 Stark D P, Kiely M, Smith A. et al . Anxiety disorders in cancer patients: Their nature, associations, and relation to quality of life. J Clin Oncol. 2002; 20 3137-3148
- 10 Grassi L, Travado L, Moncayo F L. et al . Psychosocial morbidity and its correlates in cancer patients of the Mediterranean area: findings from the Southern European Psycho-Oncology Study. J Affect Disord. 2004; 83 243-248
- 11 Keller M, Sommerfeldt S, Fischer C. et al . Recognition of distress and psychiatric morbidity in cancer patients: a multi-method approach. Ann Oncol. 2004; 15 1243-1249
- 12 Kissane D W, Grabsch B, Love A. et al . Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis. Aust NZ J Psychiatry. 2004; 38 320-326
- 13 Massie M J. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004; 32 57-71
- 14 Mehnert A, Koch U. Prevalence of acute and post-traumatic stress disorder and comorbid mental disorders in breast cancer patients during primary cancer care: A prospective study. Psycho-Oncology. 2006, in press; DOI: 10.1002/pon1057
- 15 Zabora J, BrintzenhofeSzoc K, Curbow B. et al . The prevalence of psychological distress by cancer site. Psychooncology. 2001; 10 19-28
- 16 Herschbach P, Keller M, Knight L. et al . Psychological problems in cancer patients - A cancer Distress screening with a cancer-specific questionnaire. Br J Cancer. 2004; 91 504-511
- 17 National Comprehensive Cancer Network (NCCN) .Distress treatment guidelines for patients, NCCN, ACS 2004. www.nccn.org
- 18 Passik S D, Dugan W, McDonald M V. et al . Oncologists' recognition of depression in their patients with cancer. J Clin Oncol. 1998; 16 1594-1600
- 19 Fallowfield L, Ratcliffe D, Jenkins V, Saul J. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer. 2001; 84 (8) 1011-1015
- 20 Mehnert A, Koch U. Psychosocial care of cancer patients - International differences in definition, healthcare structures, and therapeutic approaches. Support Care Cancer. 2005; 13 (8) 579-588
- 21 Holland J C, Jacobsen P B, Riba M B. NCCN Fever and Neutropenia Practice Guidelines Panel. NCCN: Distress management. Cancer Control. 2001; 8 (6, Suppl 2) 88-93
- 22 National Breast Cancer Centre Psychosocial Working Group (NHMRC) .Psychosocial practice guidelines: information, support and counselling for women with breast cancer. 1999 www.health.gov.au:80/nhmrc/publications
- 23 Canadian Association of Psychosocial Oncology (CAPO) .National Psychosocial Oncology Standards for Canada. 1999 www.capo.ca
- 24 Kiss A. Psychosocial/psychotherapeutic interventions in cancer patients: consensus statment. Support Care Cancer. 1995; 3 217-218
- 25 Weis J, Blettner G, Schwarz R. Psychoonkologische Versorgung in Deutschland. Qualität und Quantität. Zeitschrift Psychosomatische Medizin und Psychotherapie. 2000; 46 4-17
- 26 Mehnert A, Petersen C, Koch U. Empfehlungen zur psychoonkologischen Versorgung im Akutkrankenhaus. Z Med Psychol. 2003; 12 2
- 27 Holland J C. History of Psycho-Oncology: overcoming attitudinal and conceptual barriers. Psychosom Med. 2002; 64 206-221
- 28 Ford S, Fallowfield L, Lewis S. Doctor-patient interactions in oncology. Soc Sci Med. 1996; 42 1511-1519
-
29 Pouget-Schors D, Degner H.
Erkennen des psychosozialen Behandlungsbedarfs bei Tumorpatienten. In: Sellschopp A, Fegg M, Frick E, Gruber U, Pouget-Schors D, Theml H, Vodermaie A, Vollmer T (Hrsg) Psychoonkologie. München; Zuckschwerdt Verlag 2005: 30-36 - 30 Spiegel D, Sands S, Koopman C. Pain and depression in patients with cancer. Cancer. 1994; 74 2570-2578
- 31 Lundberg J C, Passik S D. Alcohol and cancer: a review for psycho-oncologists. Psychooncology. 1997; 6 253-266
- 32 Parker P A, Baile W F, Moor C de, Cohen L. Psychosocial and demographic predictors of quality of life in a large sample of cancer patients. Psychooncology. 2003; 12 183-193
- 33 Pitceathly C, Maguire P. The psychological impact of cancer on patients' partners and other key relatives: a review. Eur J Cancer. 2003; 39 1517-1524
- 34 Carlson L E, Bultz B D. Efficacy and medical cost offset of psychosocial interventions in cancer care: making the case for economic analyses. Psychooncology. 2004; 13 837-849
- 35 Prieto J M, Atala J, Blanch J. et al . Role of Depression As a Predictor of Mortality Among Cancer Patients After Stem-Cell Transplantation. J Clin Oncol. 2005; 23 6063-6071
- 36 Stieglitz R-D, Baumann U, Freyberger H J (Hrsg). Psychodiagnostik in Klinischer Psychologie, Psychiatrie, Psychotherapie (2. Aufl.). Stuttgart; Thieme 2001
-
37 Schumacher J, Brähler E.
Klinische Psychodiagnostik. In: Strauß B, Caspar F, Hohagen F (Hrsg) Lehrbuch Psychotherapie. Göttingen; Hogrefe 2006 - 38 Wittchen H U, Zaudig M, Fydrich T. SKID. Strukturiertes Klinisches Interview für DSM-IV. Achse I und II. Handanweisung. Göttingen; Hogrefe 1997
- 39 Wittchen H U, Semmler G. Composite International Diagnostic Interview (CIDI): Interviewerheft/World Health Organization. Weinheim; Beltz Test 1990
- 40 Bortz J, Döring N. Forschungsmethoden und Evaluation für Human- und Sozialwissenschaftler. Heidelberg; Springer 2002
- 41 Nunnally J C, Bernstein I H. Psychometric Theory. New York; McGraw-Hill 1994
- 42 Herschbach P, Brandl T, Knight L, Keller M. Das subjektive Befinden von Krebskranken einheitlich beschreiben - Vorstellung der Psycho-Onkologischen Basisdokumentation (PO-Bado). Dtsch Ärztebl. 2004; 101 799-802
- 43 Herschbach P. Behandlungsbedarf in der Psychoonkologie: Grundlagen und Erfassungsmethoden. Onkologe. 2006; 12 41-47
- 44 Roth A J, Kornblith A B, Batel-Copel L. et al . Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer. 1998; 82 1904-1908
- 45 Jacobsen P B, Donovan K A, Trask P C. et al . Screening for Psychological Distress in Ambulatory Cancer Patients: A Multi-Center Evaluation of the Distress Thermometer. Cancer. 2005; 103 1494-1502
- 46 Mehnert A, Müller D, Lehmann C, Koch U. Deutsche Die deutsche Version des NCCN Distress-Thermometers - Empirische Prüfung eines Screening-Instruments zur Erfassung psychosozialer Belastung bei Krebspatienten. Zeitschrift für Psychiatrie, Psychologie und Psychotherapie. 2006; 54 (3) 213-223
- 47 Derogatis L R. Brief Symptom Inventory. Baltimore; Clincial Psychometric Research 1975
- 48 Derogatis L R, Melisaratos N. The Brief Symptom Inventory: An introductory report. Psychological Medicine. 1983; 13 595-605
- 49 Franke G H. BSI. Brief Symptom Inventory von Derogatis L R (Kurzform der SCL-90-R). Deutsche Version. Manual. Göttingen; Beltz-Test 2000
- 50 Franke G H. Die Symptom-Checkliste von Derogatis L R (SCL-90-R) - Deutsche Version. (2. vollst. überarb. u. neu norm. Version) - Manual. Göttingen; Hogrefe 2002
- 51 Herschbach P, Marten-Mittag B, Henrich G. Revision und psychometrische Prüfung des Fragebogens zur Belastung von Krebskranken (FBK-R23). Z Med Psychol. 2003; 12 1-8
- 52 Herschbach P, Keller M, Knight L. et al . Psychological Problems of Cancer Patients - A Cancer Distress Screening with a Cancer-Specific Questionnaire. Br J Cancer. 2004; 91 504-511
- 53 Tilkorn M, Mawick R, Sommerfeld S, Strittmatter G. Lebensqualität von Patienten mit bösartigen Gesichts- und Hauttumoren. Entwicklung eines Fragebogens und erste Ergebnisse einer Studie. Rehabilitation. 1990; 29 134-139
- 54 Strittmatter G. Indikation zur Intervention in der Psychoonkologie. Psychosoziale Belastungen und Ermittlung der Betreuungsbedürftigkeit stationärer Hauttumorpatienten. Münster; Waxmann 1997
- 55 Strittmatter G, Mawick R, Tilkorn M. Development of the Hornheide Screening Instrument (HSI) for the identification of cancer patients in need of support. J Cancer Res Clin Oncol. 2000; 126 (Suppl) R 36
- 56 Strittmatter G, Tilkorn M, Mawick R. How to identify patients in need of psychological intervention. Recent Results Cancer Res. 2002; 160 353-361
- 57 McNair D M, Lorr M, Droppleman L F. Manual for the Profile of Mood States. San Diego, CA; Edits/Educational and Industrial Testing Service 1971
- 58 Cella D F, Jacobsen P B, Orav E J. et al . A brief POMS measure of distress for cancer patients. J Chronic Dis. 1987; 40 (10) 939-942
- 59 McNair D M, Lorr M, Droppleman L F. Edits Manual for the Profile of Mood States. San Diego, CA; Edits/Educational and Industrial Testing Service 1992
- 60 Bullinger M, Heinisch M, Ludwig M, Geier S. Skalen zur Erfassung des Wohlbefindens: Psychometrische Analysen zum „Profile of Mood States” (POMS) und zum „Psychological General Wellbeing Index” (PGWB). Zeitschrift für Differentielle und Diagnostische Psychologie. 1990; 11 53-61
- 61 Goldberg D, Williams P. A user's guide to the General Health Questionnaire. London; Nfer-Nelson 1988
- 62 Hobi V, Gerhard U, Gutzwiller F. Mitteilungen über die Erfahrungen mit dem GHQ (General Health Questionaire) von D. G. Goldberg. Schw Med Rundsch (Praxis). 1989; 78 219-225
- 63 Goldberg D P, Gater R, Sartorius N. et al . The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med. 1997; 27 191-197
- 64 Linden M, Maier W, Achberger M. et al . Psychische Erkrankungen und ihre Behandlung in Allgemeinarztpraxen in Deutschland. Nervenarzt. 1996; 67 205-215
- 65 Spitzer R L, Kroenke K, Williams J B. Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. JAMA. 1999; 282 1737-1744
- 66 Löwe B, Spitzer R L, Zipfel S, Herzog W. Der Gesundheitsfragebogen für Patienten (PHQ-D). Manual und Testunterlagen (2. Auflage). Karlsruhe; Pfizer 2000
- 67 Löwe B, Unutzer J, Callahan C M. et al . Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care. 2004; 42 1194-1201
- 68 Löwe B, Kroenke K, Grafe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res. 2005; 58 163-171
- 69 Haes J C de, Knippenberg F C van, Neijt J P. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer. 1990; 62 (6) 1034-1038
- 70 Stein K D, Denniston M, Baker F. et al . Validation of a modified Rotterdam Symptom Checklist for use with cancer patients in the United States. J Pain Symptom Manage. 2003; 26 (5) 975-989
- 71 Haes J C de, Olschewski M. Quality of life assessment in a cross-cultural context: use of the Rotterdam Symptom Checklist in a multinational randomised trial comparing CMF and Zoladex (Goserlin) treatment in early breast cancer. Ann Oncol. 1998; 9 745-750
- 72 Morasso G, Costantini M, Baracco G. et al . Assessing psychological distress in cancer patients: validation of a self-administered questionnaire. Oncology. 1996; 53 (4) 295-302
- 73 Bonevski B, Sanson-Fisher R, Girgis A. et al . Evaluation of an instrument to assess the needs of patients with cancer. Supportive Care Review Group. Cancer. 2000; 88 217-225
- 74 Sanson-Fisher R, Girgis A, Boyes A. et al . The unmet supportive care needs of patients with cancer. Supportive Care Review Group. Cancer. 2000; 88 226-237
- 75 Zigmond A S, Snaith R P. The Hospital and Depression Scale. Acta Psychiatrica Scandinavica. 1983; 67 361-370
- 76 Hermann C, Buss U, Snaith R P. HADS-D: Hospital Anxiety and Depression Scale - Deutsche Version. Ein Fragebogen zur Erfassung von Angst und Depressivität in der somatischen Medizin. Bern; Huber 1995
- 77 Laux L, Glanzmann P, Schaffner P, Spielberger C D. Das State-Trait-Angstinventar. Theoretische Grundlagen und Handanweisung. Weinheim; Beltz 1981
- 78 Chlan L, Savik K, Weinert C. Development of a shortened state anxiety scale from the Spielberger State-Trait Anxiety Inventory (STAI) for patients receiving mechanical ventilatory support. J Nurs Meas. 2003; 11 283-293
- 79 Zung W W. A rating instrument for anxiety disorders. Psychosomatics. 1971; 12 371-379
- 80 Beck A T, Epstein N, Brown G, Steer R A. An inventory measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol. 1988; 56 893-897
- 81 Beck A T, Steer R A. Manual for the Beck Anxiety Inventory. San Antonio, TX; Psychological Corporation 1990
- 82 Dankert A, Duran G, Engst-Hastreiter U. et al . Fear of progression in patients with cancer, diabetes mellitus and chronic arthritis. Rehabilitation. 2003; 42 (3) 155-163
- 83 Herschbach P, Berg P, Dankert A. et al . Fear of progression in chronic diseases: psychometric properties of the Fear of Progression Questionnaire. J Psychosom Res. 2005; 58 505-511
- 84 Mehnert A, Herschbach P, Berg P. et al . Progredienzangst bei Brustkrebspatientinnen - Validierung der Kurzform des Progredienzangstfragebogens PA-F-KF. Psychother Psych Med. 2006; 52 274-288
- 85 Roth A J, Rosenfeld B, Kornblith A B. et al . The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with prostate cancer. Cancer. 2003; 97 2910-2918
- 86 Lehmann C, Mehnert A, Schulte T, Koch U. Erfassung krebs- und behandlungsspezifischer Ängste bei Prostatakrebspatienten in der Rehabilitation: Der Memorial Angst-Fragebogen für Prostatakrebs (MAX-PC). Praxis Klinische Verhaltensmedizin und Rehabilitation. 2006, in press;
- 87 Kissane D W, Clarke D M, Street A F. Demoralization syndrome - a relevant psychiatric diagnosis for palliative care. (Review). J Palliat Care. 2001; 17 (1) 12-21
- 88 Beck A T, Ward C H, Mendelson M. et al . An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4 561-571
- 89 Hautzinger M, Bailer M, Worall H, Keller F. Beck-Depressions-Inventar (BDI). Bern, Göttingen, Toronto, Seattle; Verlag Hans Huber 1994
- 90 Steer R A, Ranieri W F, Kumar G, Beck A T. Beck Depression Inventory-II items associated with self-reported symptoms of ADHD in adult psychiatric outpatients. J Pers Assess. 2003; 80 (1) 58-63
- 91 Zung W W. A self-rating depression scale. Arch Gen Psychiatry. 1965; 12 63-70
- 92 Radloff L S. The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement. 1977; 1 385-401
- 93 Radloff L S. The Use of the Center for Epidemiologic Studies Depression Scale in Adolescents and Young Adults. Youth Adolesc. 1991; 20 (2) 149-166
- 94 Hann D, Winter K, Jacobsen P. Measurement of depressive symptoms in cancer patients: Evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res. 1999; 46 437-443
- 95 Yesavage J A, Brink T L, Rose T L. et al . Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res. 1983; 17 37-49
- 96 Sheikh J I, Yesavage J A, Brooks III J O. et al . Proposed factor structure of the Geriatric Depression Scale. Int Psychogeriatr. 1991; 3 23-28
- 97 Horowitz M J, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med. 1979; 41 209-218
-
98 Weiss D S, Marmar C R.
The Impact of Event Scale - Revised. In: Wilson J P, Keane T M (eds) Assessing psychological trauma and PTSD. New York; Guilford Press 1996: 399-411 - 99 Maercker A, Schützwohl M. Erfassung von psychischen Belastungsfolgen: Die Impact of Event Skala - Revidierte Version (IES-R). Diagnostica. 1998; 44 (3) 130-141
- 100 Weathers F W, Huska J A, Keane T M. PCL-C for DSM-IV. Boston; National Center for PTSD - Behavioral Science Division 1991
- 101 Teegen F. Deutsche Übersetzung der Posttraumatic Stress Disorder Checklist (PCL-C) des National Center for PTSD. Hamburg; Universität Psychologisches Institut III 1997
- 102 Davidson J RT, Book S W, Colket J T. et al . Assessment of a new self-rating scale for post-traumatic stress disorder. Psychol Med. 1997; 27 153-160
- 103 Foa E B, Cashman L, Jaycox L, Perry K. The validation of a self-report measure of posttraumatic stress disorder: The Posttraumatic Diagnostic Scale. Psychol Assess. 1997; 9 445-451
- 104 Jacobsen P B. Assessment of fatigue in cancer patients. Review. J Natl Cancer Inst Monogr. 2004; (32) 93-97
- 105 Mendoza T R, Wang X S, Cleeland C S. et al . The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999; 85 1186-1196
- 106 Radbruch L, Sabatowski R, Elsner F. et al . Validation of the German Version of the Brief Fatigue Inventory. J Pain Sympt Manage. 2003; 25 449-458
- 107 Okuyama T, Akechi T, Kugaya A. et al . Development and validation of the cancer fatigue scale: a brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients. J Pain Symptom Manage. 2000; 19 5-14
- 108 Hann D M, Jacobsen P B, Azzarello L M. et al . Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res. 1998; 7 (4) 301-310
- 109 Smets E MA, Garssen B, Bonke B, Haes J CHM de. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995; 39 315-325
- 110 Smets E MA, Garssen B, Cull A, Haes J CHM de. Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br J Cancer. 1996; 73 241-245
- 111 Brähler E, Gunzelmann T, Hinz A, Schwarz R. Das Ausmaß von Müdigkeit und Erschöpfbarkeit in der über 60-jährigen Normalbevölkerung in Deutschland. Psychotherapeut. 2001; 46 332-338
- 112 Schwarz R, Krauss O, Hinz A. Fatigue in the general population. Onkologie. 2003; 26 140-144
- 113 Bruera E, Miller L, McCallion J. et al . Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symptom Manage. 1992; 7 (4) 192-195
- 114 Pereira J, Hanson J, Bruera E. The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer. 1997; 79 835-841
- 115 Massie M J, Holland J C, Glass E. Delirium in terminally ill cancer patients. Am J Psychiatry. 1983; 140 1048-1050
- 116 Fainsinger R, Young C. Cognitive failure in a terminally ill patient. J Pain and Symptom Management. 1991; 6 492-494
- 117 Breitbart W, Rosenfeld B, Roth A. et al . The Memorial Delirium Assessment Scale. J Pain Symptom Manage. 1997; 13 (3) 128-137
- 118 Trzepacz P T, Baker R W, Greenhouse J. A symptom rating scale for delirium. Psychiatry Res. 1988; 23 (1) 89-97
- 119 Trzepacz P T, Dew M A. Further analyses of the Delirium Rating Scale. Gen Hosp Psychiatry. 1995; 17 (2) 75-79
- 120 Trzepacz P T, Mittal D, Torres R. et al . Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci. 2001; 13 (2) 229-242
- 121 Schuurmans M J, Deschamps P I, Markham S W. et al . The measurement of delirium: review of scales. Res Theory Nurs Pract. 2003; 17 (3) 207-224
- 122 Schuurmans M J, Shortridge-Baggett L M, Duursma S A. The Delirium Observation Screening Scale: a screening instrument for delirium. Res Theory Nurs Pract. 2003; 17 (1) 31-50
- 123 Folstein M F, Folstein S E, McHugh P R. „Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12 (3) 189-198
- 124 Kessler J, Denzler P, Markowitsch H J. Mini-Mental-Status-Test (MMST) - Manual. Göttingen; Hogrefe 1990
-
125 Rowland J H.
Intrapersonal resources: coping. In: Holland J C, Rowland JH (eds) Handbook of Psychooncology: Psychological Care of the Patient With Cancer. New York, NY; Oxford University Press 1989: 44-57 - 126 Heim E. Coping und Adaptivität: Gibt es ein geeignetes oder ungeeignetes Coping?. Psychother Psych Med. 1988; 38 8-18
- 127 Heim E. Coping - Erkenntnisstand der 90er Jahre. Psychother Psych Med. 1998; 48 321-337
- 128 Baider L, Cooper C L, Kaplan De-Nour A. Cancer and the family 2nd ed. Chichester; Wiley 2000: 257-268
- 129 Schulz K H, Schulz H, Schulz O, Kerekjarto M. Krebspatienten und ihre Familien. Wechselseitige Belastung und Unterstützung. Stuttgart; Schattauer 1998
- 130 Watson M, Greer S, Young J. et al . Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med. 1988; 18 (1) 203-209
- 131 Greer S, Moorey S, Watson M. Patients' adjustment to cancer: the Mental Adjustment to Cancer (MAC) scale vs clinical ratings. J Psychosom Res. 1989; 33 (3) 373-377
- 132 Greer S. Psychological response to cancer and survival. Psychol Med. 1991; 21 43-49
- 133 Watson M, Law M, Santos M dos. et al . The Mini-MAC: Further development of the Mental Adjustment to Cancer Scale. J Psychosoc Oncol. 1994; 12 33-46
- 134 Folkman S, Lazarus R S. If it changes it must be a process: Study of emotion and coping during three stages of a college examination. Pers Soc Psychol. 1985; 48 150-170
- 135 Folkman S, Lazarus R S, Dunkel-Schetter C. et al . The dynamics of a stressful encounter: Cognitive appraisal, coping and encounter outcomes. Pers Soc Psychol. 1986; 50 992-1003
- 136 Ferring D, Filipp S H. Die SEBV. Bewältigung kritischer Lebensereignisse: erste Erfahrungen mit einer deutschsprachigen Version der „Ways of Coping Checklist”. Zeitschrift für Differentielle und Diagnostische Psychologie. 1989; 10 (4) 189-199
- 137 Namir S, Wolcott D L, Fawzy I F, Alumbaugh M J. Coping with AIDS: Psychological and Health Implications. Journal of Applied Psychology. 1987; 17 (3) 309-328
- 138 Zaun S. Psychometrische Überprüfung und Weiterentwicklung des Dealing with Illness Inventory - Revised an einer Stichprobe aus einer onkologischen Rehabilitationsklinik. Unveröff. Diss. Hamburg; Universitätsklinikum Hamburg-Eppendorf 2002
- 139 Fawzy F I, Cousins N, Fawzy N W. et al . A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance. Arch Gen Psychiatry. 1990; 47 (8) 720-725
- 140 Morrow G R, Chiarello R J, Derogatis L R. A new scale for assessing patients' psychosocial adjustment to medical illness. Psychol Med. 1978; 8 (4) 605-610
- 141 Derogatis L R. The psychosocial adjustment to illness scale (PAIS). J Psychosom Res. 1986; 30 (1) 77-91
- 142 Moorey S, Frampton M, Greer S. The Cancer Coping Questionnaire: a self-rating scale for measuring the impact of adjuvant psychological therapy on coping behaviour. Psychooncology. 2003; 12 (4) 331-344
- 143 Muthny F A. Freiburger Fragebogen zur Krankheitsverarbeitung FKV-LIS. Weinheim; Beltz Test GmbH 1989
-
144 Muthny F A.
Zur Spezifität der Krankheitsverarbeitung. In: Muthny FA (Hrsg) Krankheitsverarbeitung. Berlin; Springer 1990: 143-166 - 145 Klauer T, Filipp S H. Trierer Skalen zur Krankheitsbewältigung (TSK). In: Testkatalog 1998/99, 240. Göttingen, Bern; Testzentrale 1993
- 146 Cobb S. Social support as a moderator of life stress. Psychosom Med. 1976; 38 300-314
- 147 Sommer G, Fydrich T. Entwicklung und Überprüfung eines Fragebogens zur sozialen Unterstützung (F-SOZU). Diagnostica. 1991; 37 160-178
- 148 Fydrich T, Sommer G, Menzel U, Höll B. Fragebogen zur sozialen Unterstützung (Kurzform; SOZU-K-22). Zeitschrift für Klinische Psychologie. 1987; 4 434-436
- 149 Revenson T A, Majerowitz S D. Illness-Specific Social Support Scale. As a part of patient and marital adaptions to rheumatic disease study. New York; City University 1992
- 150 Ramm G C, Hasenbring M. Die deutsche Adaptation der Illness-specific Social Support Scale und ihre teststatistische Überprüfung beim Einsatz an Patienten vor und nach Knochenmarktransplantation. Z Med Psychol. 2003; 12 29-38
-
151 Cohen S, Mermelstein R, Kamarck T, Hoberman H M.
Measuring the functional components of social support. In: Sarason IG, Sarason BR (eds) Social support: theory, research, and applications. The Hague; Martinus Nijhoff 1985: 73-94 - 152 Brookings J B, Bolton B. Confirmatory factor analysis of the Interpersonal Support Evaluation List. Am J Community Psychol. 1988; 16 (1) 137-147
- 153 Sherbourne C D, Stewart A L. The MOS social support survey. Soc Sci Med. 1991; 32 (6) 705-714
- 154 Sarason I G, Levin M H, Bashman R B, Saranson B R. Assessing social support: the social support questionnaire. J Pers Soc Psychol. 1983; 44 127-139
- 155 Broadhead W E, Kaplan B H. Social support and the cancer patient. Implications for future research and clinical care. Cancer. 1991; 67 (3, Suppl) 794-799
- 156 Broadhead W E, Gehlbach S H, Gruy F V de, Kaplan B H. The Duke-UNC Functional Social Support Questionnaire. Measurement of social support in family medicine patients. Med Care. 1988; 26 (7) 709-723
- 157 Aaronson N K, Meyerowitz B E, Bard M. et al . Quality of life research in oncology. Past achievements and future priorities. Cancer. 1991; 67 839-843
- 158 Leplege A, Hunt S. The problem of quality of life in medicine. JAMA. 1997; 278 47-50
- 159 Ferrell B R, Dow K H. Quality of life among long-term cancer survivors. Oncology. 1997; 11 (4) 565-576
-
160 Bullinger M, Petersen C, Mehnert A.
Erfassung der Lebensqualität in der Onkologie. In: Siewert JR, Rothmund M, Schumpelick V (Hrsg) Praxis der Viszeralchirurgie - Onkologische Chirurgie. Heidelberg; Springer Medizin Verlag 2005: 323-332 - 161 Aaronson N K, Ahmedzai S, Bergman B. et al . The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85 (5) 365-376
-
162 Aaronson N K, Cull A M, Kaasa S, Sprangers M AG.
The European Organization for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology: An update. In: Spilker B (eds) Quality of life and pharmaeconomics in clinical trials. Philadelphia; Lippincott-Raven 1996: 179-190 - 163 Cella D F, Tulsky D S, Gray G. et al . The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993; 11 (3) 570-579
-
164 Cella D F, Bonomi A E.
The Functional Assessment of Cancer Therapy (FACT) and Functional Assessment of HIV Infection (FAHI) quality of life measurement system. In: Spilker B (eds) Quality of life and pharmaeconomics in clinical trials. Philadelphia; Lippincott-Raven 1996: 203-214 - 165 Bonomi A E, Cella D F, Hahn E A. et al . Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Qual Life Res. 1996; 5 (3) 309-320
- 166 Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. J Clin Oncol. 1984; 2 (5) 472-483
-
167 Clinch J J.
The Functional Living Index-Cancer: Ten years later. In: Spilker B (ed) Quality of life and pharmaeconomics in clinical trials. Philadelphia; Lippincott-Raven 1996: 215-226 -
168 Padilla G V, Grant M M, Ferrell B R, Presant C A.
Quality of life - Cancer. In: Spilker B (ed) Quality of life and pharmaeconomics in clinical trials. Philadelphia; Lippincott-Raven 1996: 301-308 - 169 Ware Jr J, Kosinski M, Keller S D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996; 34 (3) 220-233
-
170 Ware J E.
The SF-36 Health Survey. In: Spilker B (ed) Quality of life and pharmaeconomics in clinical trials. Philadelphia; Lippincott-Raven 1996: 337-346 - 171 Bullinger M, Kirchberger I, Ware J. Der deutsche SF-36 Health Survey. Übersetzung und psychometrische Testung eines krankheitsübergreifenden Instrumentes zur Erfassung der gesundheitsbezogenen Lebensqualität. Z Gesundheitswiss. 1995; 1 21-36
-
172 Orley J. and the WHOQOL Group .
The development of the WHO Quality of Life Assessment Instruments (The WHOQOL). In: Orley J, Kuyken W (eds) Quality of life assessment: International perspectives. Berlin; Springer Verlag 1994: 41-57 -
173 Szabo S. (the WHOQOL Group) .
The World Health Organization Quality of Life (WHOQOL) Assessment Instrument. In: Spilker B (ed) Quality of life and pharmaeconomics in clinical trials. Philadelphia; Lippincott-Raven 1996: 355-362 - 174 Szabo S, Orley J, Saxena S. An approach to response scale development for cross-cultural questionnaires. European Psychologist. 1997; 2 (3) 270-276
- 175 WHOQOL Group. The World Health Organization quality of life assessment (WHOQOL) . Development and general psychometric properties. Social Science and Medicine. 1998; 46 (12) 1569-1585
- 176 WHOQOL Group . Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine. 1998; 28 551-558
- 177 Bergner M, Bobbitt R A, Carter W B, Gilson B S. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981; 19 (8) 787-805
-
178 Damiano A M.
The Sickness Impact Profile. In: Spilker B (ed) Quality of life and pharmaeconomics in clinical trials. Philadelphia; Lippincott-Raven 1996: 347-354 - 179 Hunt S M, McKenna S P, McEwen J. et al . The Nottingham Health Profile: subjective health status and medical consultations. Soc Sci Med. 1981; 15 (3 Pt 1) 221-229
-
180 McEwen J, McKenna S P.
Nottingham Health Profile. In: Spilker B (ed) Quality of life and pharmaeconomics in clinical trials. Philadelphia; Lippincott-Raven 1996: 281-286 - 181 Fawzy F I, Fawzy N W, Arndt L A, Pasnau R O. Critical review of psychosocial interventions in cancer care. Arch Gen Psychiat. 1995; 52 100-113
- 182 Meyer T J, Mark M M. Effects of psychosocial interventions with adult cancer patients: A meta-analysis of randomized experiments. Health Psychol. 1995; 14 101-108
- 183 Newell S A, Sanson-Fisher R W, Savolainen N J. Systematic review of psychological therapies for cancer patients: overview and recommendations for future research. JNCI. 2003; 94 558-584
- 184 Rehse B, Pukrop R. Effects of psychosocial interventions on quality of life in adult cancer patients: meta analysis of 37 published controlled outcome studies. Patient Educ Couns. 2003; 50 179-186
- 185 Trask P C, Paterson A G, Griffith K A. et al . Cognitive-behavioral intervention for distress in patients with melanoma: comparison with standard medical care and impact on quality of life. Cancer. 2003; 98 854-864
- 186 Goodwin P J, Ennis M, Bordeleau L J. et al . Health-related quality of life and psychosocial status in breast cancer prognosis: analysis of multiple variables. J Clin Oncol. 2004; 15, 22 (20) 4184-4192
- 187 Goodwin P J. Support groups in breast cancer: when a negative result is positive. J Clin Oncol. 2004; 22 (21) 4244-4246
- 188 Rumpold G, Augustin M, Zschocke I. et al . Die Validität des Hornheider Fragebogens zur psychosozialen Unterstützung bei Tumorpatienten. Eine Untersuchung an zwei repräsentativen ambulanten Stichproben von Melanompatienten. Psychother Psych Med. 2001; 51 (1) 25-33
- 189 Maguire P. Improving communication with cancer patients. (Review). Eur J Cancer. 1999; 35 (14) 2058-2065
Dr. phil. Anja Mehnert
Institut und Poliklinik für Medizinische Psychologie, Zentrum für Psychosoziale Medizin, Universitätsklinikum Hamburg-Eppendorf
Martinistraße 52, S 35
20246 Hamburg
Email: mehnert@uke.uni-hamburg.de